View in EDS

Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases.

Saved in:
Bibliographic Details
Title: Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases.
Authors: Davies LC; NextCell Pharma AB, Huddinge, Sweden; QVance AB, Huddinge, Sweden; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. Electronic address: Lindsay.davies@nextcellpharma.com., Biard L; INSERM U1342, Team ECSTRRA, Paris, France; Université Paris Cité, Paris, France; Department of Biostatistics and Medical Informatics, Assistance Publique Hôpitaux de Paris, Paris, France., García-Olmo D; Department of Surgery, Fundación Jiménez Díaz University Hospital, UAM, Madrid, Spain., Gilkeson G; Medical University of South Carolina, Charleston, South Carolina, USA., Gnecchi M; Department of Molecular Medicine, Unit of Cardiology, University of Pavia, Pavia, Italy; Cardiothoracovascular Department, Translational Cardiology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Kurtzberg J; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA., Kogler G; Institute for Transplantation Diagnostics and Cell Therapy, Düsseldorf, Germany., Blanc KL; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden; Department of Cell Therapies and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden., Lowdell MW; Department of Haematology, University College London, London, UK., Pers YM; IRMB, University of Montpellier, INSERM, CHU Montpellier, Montpellier, France; Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Department of Rheumatology, Lapeyronie University Hospital, Montpellier, France., Sun LY; Department of Rheumatology and Immunology, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China., Tarte K; UMR U1236, INSERM, Univ Rennes, Etablissement Français du Sang, Immunology and Cell Therapy Lab, Rennes University, Rennes, France; SITI Laboratory, CHU Rennes, Etablissement Français du Sang, Rennes, France., Uccelli A; Department of Neurosciences, Ophthalmology and Genetics, University of Genoa, Italy., Sanchez-Guijo F; University of Salamanca, IBSAL-University Hospital of Salamanca, Salamanca, Spain., Farge D; Université Paris Cité, Paris, France; Department of Internal Medicine, CRMR MATHEC, Maladies Auto-Immunes et Thérapie Cellulaire, Centre de Référence des Maladies Auto-Immunes Systémiques Rares d'Ile-de-France, FAI2R, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris, Paris, France; Department of Medicine, McGill University, Montreal, Quebec, Canada.
Corporate Authors: ISCT Educational Course Working Group on the Use of Mesenchymal Stromal Cells for Autoimmune Diseases (Paris 2024)
Source: Cytotherapy [Cytotherapy] 2025 Nov; Vol. 27 (11), pp. 1326-1337. Date of Electronic Publication: 2025 Jul 12.
Publication Type: Consensus Statement; Guideline; Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40828119
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Davies+LC%22">Davies LC</searchLink>; NextCell Pharma AB, Huddinge, Sweden; QVance AB, Huddinge, Sweden; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. Electronic address: Lindsay.davies@nextcellpharma.com.<br /><searchLink fieldCode="AU" term="%22Biard+L%22">Biard L</searchLink>; INSERM U1342, Team ECSTRRA, Paris, France; Université Paris Cité, Paris, France; Department of Biostatistics and Medical Informatics, Assistance Publique Hôpitaux de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22García-Olmo+D%22">García-Olmo D</searchLink>; Department of Surgery, Fundación Jiménez Díaz University Hospital, UAM, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gilkeson+G%22">Gilkeson G</searchLink>; Medical University of South Carolina, Charleston, South Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Gnecchi+M%22">Gnecchi M</searchLink>; Department of Molecular Medicine, Unit of Cardiology, University of Pavia, Pavia, Italy; Cardiothoracovascular Department, Translational Cardiology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Kurtzberg+J%22">Kurtzberg J</searchLink>; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Kogler+G%22">Kogler G</searchLink>; Institute for Transplantation Diagnostics and Cell Therapy, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Blanc+KL%22">Blanc KL</searchLink>; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden; Department of Cell Therapies and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Lowdell+MW%22">Lowdell MW</searchLink>; Department of Haematology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Pers+YM%22">Pers YM</searchLink>; IRMB, University of Montpellier, INSERM, CHU Montpellier, Montpellier, France; Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Department of Rheumatology, Lapeyronie University Hospital, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Sun+LY%22">Sun LY</searchLink>; Department of Rheumatology and Immunology, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Tarte+K%22">Tarte K</searchLink>; UMR U1236, INSERM, Univ Rennes, Etablissement Français du Sang, Immunology and Cell Therapy Lab, Rennes University, Rennes, France; SITI Laboratory, CHU Rennes, Etablissement Français du Sang, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Uccelli+A%22">Uccelli A</searchLink>; Department of Neurosciences, Ophthalmology and Genetics, University of Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Sanchez-Guijo+F%22">Sanchez-Guijo F</searchLink>; University of Salamanca, IBSAL-University Hospital of Salamanca, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Farge+D%22">Farge D</searchLink>; Université Paris Cité, Paris, France; Department of Internal Medicine, CRMR MATHEC, Maladies Auto-Immunes et Thérapie Cellulaire, Centre de Référence des Maladies Auto-Immunes Systémiques Rares d'Ile-de-France, FAI2R, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris, Paris, France; Department of Medicine, McGill University, Montreal, Quebec, Canada.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ISCT+Educational+Course+Working+Group+on+the+Use+of+Mesenchymal+Stromal+Cells+for+Autoimmune+Diseases+%28Paris+2024%29%22">ISCT Educational Course Working Group on the Use of Mesenchymal Stromal Cells for Autoimmune Diseases (Paris 2024)</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100895309%22">Cytotherapy</searchLink> [Cytotherapy] 2025 Nov; Vol. 27 (11), pp. 1326-1337. <i>Date of Electronic Publication: </i>2025 Jul 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Consensus Statement; Guideline; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100895309 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-2566 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214653249%22">14653249 </searchLink><i>NLM ISO Abbreviation: </i>Cytotherapy <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40828119
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jcyt.2025.06.005
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1326
    Titles:
      – TitleFull: Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Davies LC
      – PersonEntity:
          Name:
            NameFull: Biard L
      – PersonEntity:
          Name:
            NameFull: García-Olmo D
      – PersonEntity:
          Name:
            NameFull: Gilkeson G
      – PersonEntity:
          Name:
            NameFull: Gnecchi M
      – PersonEntity:
          Name:
            NameFull: Kurtzberg J
      – PersonEntity:
          Name:
            NameFull: Kogler G
      – PersonEntity:
          Name:
            NameFull: Blanc KL
      – PersonEntity:
          Name:
            NameFull: Lowdell MW
      – PersonEntity:
          Name:
            NameFull: Pers YM
      – PersonEntity:
          Name:
            NameFull: Sun LY
      – PersonEntity:
          Name:
            NameFull: Tarte K
      – PersonEntity:
          Name:
            NameFull: Uccelli A
      – PersonEntity:
          Name:
            NameFull: Sanchez-Guijo F
      – PersonEntity:
          Name:
            NameFull: Farge D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1477-2566
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Cytotherapy
              Type: main
ResultId 1